A Lactobacillus strain (L9) found in centenarians reduces pulmonary fibrosis in aging mice by 30% through a metabolite-signaling pathway that suppresses collagen synthesis. The mechanism operates through the JNK signaling cascade and senescence-associated inflammatory cytokines, establishing a direct gut-to-lung biochemical axis relevant to fibrotic disease prevention.
Key Points
- L9 reduces lung fibrosis score by 30% and Col-I collagen by 59%
- Mechanism: inflammatory cytokines → JNK pathway → HSP47 reduction
- Effect operates through collagen synthesis suppression, not degradation
Longevity Analysis
Age-related pulmonary fibrosis develops through dysregulated collagen deposition driven by systemic inflammation and cellular senescence. This research demonstrates that a specific microbial strain modulates the inflammatory signals upstream of fibrotic pathology, suggesting that targeted microbial interventions can interrupt the progression of age-related tissue damage. The finding bridges two major longevity domains—microbial composition and connective tissue integrity—revealing how dysregulated signaling in one body compartment directly compromises tissue structure in another. For practitioners, this points toward the value of identifying and maintaining specific microbial strains as a measurable intervention against fibrotic diseases that accelerate functional decline.
Original published by LifeSpan.io, by Josh Conway.